Publications
62
Citations
1,493
Est. group size
—
Recurring co-author estimate
Active years
15
Publishing since 2012
This researcher studies the molecular biology of colorectal and other cancers, focusing on how inflammatory signaling molecules, hormone receptors, and immune checkpoint proteins interact to drive tumor growth, drug resistance, and metastasis. Much of the work examines specific molecular pathways (such as WNT signaling, PD-L1, estrogen receptors, and leukotriene receptors) as potential biomarkers or drug targets for improving cancer prognosis and treatment. The research combines laboratory cell studies with patient-derived data and model organisms like zebrafish to test these findings.
Publication output rose to a peak around 2019 (9 papers) then declined through the early 2020s, with a recent uptick in 2025, averaging about 3.2 papers per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Nuclear PD-L1 regulates YAP-driven transcription via the PGE2-EP4-YAP-importin α3 axis in solid tumors
Cell Reports · 2026
- Beyond boundaries: exploring the role of extracellular vesicles in organ-specific metastasis in solid tumors
Frontiers in Immunology · 2025
- Targeting Gastrointestinal Cancers with Carvacrol: Mechanistic Insights and Therapeutic Potential
Biomolecules · 2025
- MicroRNAs at the crossroad of cancer therapeutics: insights from WNT signaling & flavonoids
Frontiers in Molecular Biosciences · 2025
- Experimental toolkit to study the oncogenic role of WNT signaling in colorectal cancer
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025
- Integrating COX-2, stromal PD-L1, and T-cell infiltration enhances prognostic stratification in colorectal cancer
BMC Cancer · 2025
- High Oestrogen receptor alpha expression correlates with adverse prognosis and promotes metastasis in colorectal cancer
Cell Communication and Signaling · 2024
- Unraveling the Regulatory Role of HuR/microRNA Axis in Colorectal Cancer Tumorigenesis
Cancers · 2024
- Abstract 1994: Drug-induced cancer cell secretome promotes resistance in colon cancer
Cancer Research · 2024
- Correction: High Oestrogen receptor alpha expression correlates with adverse prognosis and promotes metastasis in colorectal cancer
Cell Communication and Signaling · 2024
- The tumor promoter cysteinyl leukotriene receptor 1 regulates PD-L1 expression in colon cancer cells via the Wnt/β-catenin signaling axis
Cell Communication and Signaling · 2023
- DNA Methylation and Gene Expression of the Cysteinyl Leukotriene Receptors as a Prognostic and Metastatic Factor for Colorectal Cancer Patients
International Journal of Molecular Sciences · 2023
- Combined Estrogen Alpha and Beta Receptor Expression Has a Prognostic Significance for Colorectal Cancer Patients
Frontiers in Medicine · 2022
- Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers
International Journal of Molecular Sciences · 2022
- Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling
Cancers · 2022
- Cancer Research×5
- Cancer Letters×4
- Cell Communication and Signaling×3
- Cancers×3
- Annals of Oncology×3
- Randall Harris
Medicine · The Ohio State University
- Randall E. Harris
Medicine · The Ohio State University
- Maxime A. Gallant
Medicine · Purdue University West Lafayette
- F.F. Sun
Medicine · Indiana University
- Hanieh Taheri
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile